On February 20, 2018, the leading chemical supplier BOC Sciences launched integrated services on drug discovery ranging from drug target identification, target validation to lead identification and led optimization.
“With the advantage of expertise in multi-disciplinary sciences, we decide to provide integrated drug discovery services to our clients who are involved with pharmaceutical industries, either small business or research institutes across the world,” says Barron Jones, the Marketing Executive of BOC Sciences. “We are here to help accelerate the discovering and characterizing of novel drug candidates for preclinical development, from hit ID to IND. Hopefully this move will make its contribution in improving patients’ lives with concerted efforts of all sides.”
The integrated drug discovery services include:
Virtual Screening
Antibody Drug Conjugates Services
Drug design
Screening Libraries
Compound Screening Platform
Formulation Service
Isotope Labeling Service
Fluorine Chemistry Service
With over a decade of years’ experience in the pharmaceutical industry, BOC Sciences has acquired intensive drug discovery knowledge in computational modeling and design, medicinal chemistry such as library synthesis and SAR studies, biological sciences, pharmaceutical development, protein crystallography, etc. Also with expertise in project management, BOC Sciences succeeded in forming its own unique integrated platform in drug discovery.
“We have in silico docking to predict the drug-protein binding pocket for our clients, to assist in design and selecting bioactive small molecules. Our medicinal chemistry experts can solve challenging synthetic organic chemistry problems to support the project in a timely manner. Our crystallography team supports on protein structure characterizations. Our in-house biological partners, specialized on assay development, have strong capabilities in target validation and compound screening process,” further adds Barron Jones.
About BOC Sciences
As a trust-worthy chemical supplier, BOC Sciences has been providing a wide collection of products ranging from inhibitors, metabolites to natural compounds, stem cell molecules in the last decade and more. With the expansion of businesses, BOC Sciences launched a string of services from antibody-drug conjugates to chiral synthesis, etc. Meanwhile, BOC Sciences never forgets its mission of enhancing the well-being of mankind and endeavors to keep up with the latest industry trend, striving to accelerate the R&D process in drug discovery.
Media Contact
Company Name: BOC Sciences
Contact Person: Linna Green
Email: account@bocsci.com
Phone: 0631 619 7922
Address:45-16 Ramsey Road
City: Shirley
State: NY 11967
Country: United States
Website: www.bocsci.com